中国学者近期发表的论文
1.	Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients. Author: Song P1, Cui X1, Bai L2, Zhou X3, Zhu X4, Zhang J5, Jin F6, Zhao J7, Zhou C8, Zhou Y9, Zhang X10, Wang K11, Wang Q12, Yu Y13, Zhang X13, Bai C14, Zhang L1. Journal: Thorac Cancer. 2019 May;10(5):1303-1309. doi: 10.1111/1759-7714.13078. Epub 2019 Apr 23.    PubMed      DOI
2.	Localized RNA interference therapy to eliminate residual lung cancer after incomplete microwave ablation. Author: Cao F1, Wan C2, Xie L1, Qi H1, Shen L1, Chen S1, Song Z3, Fan W1. Journal: Thorac Cancer. 2019 Apr 24. doi: 10.1111/1759-7714.13079. [Epub ahead of print]    PubMed      DOI
3.	Investigation of the effect of P14 promoter aberrant methylation on the biological function of human lung cancer cells. Author: Jia BY1, Yang RH1, Jiao WJ1, Tian KH1. Journal: Thorac Cancer. 2019 Apr 24. doi: 10.1111/1759-7714.13082. [Epub ahead of print]    PubMed      DOI
4.	Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody. Author: Wang X1, Zhang B1, Chen X1, Mo H1, Wu D2, Lan B1, Li Q1, Xu B1, Huang J1. Journal: Thorac Cancer. 2019 Apr 24. doi: 10.1111/1759-7714.13083. [Epub ahead of print]    PubMed      DOI
5.	Safety and efficacy of thermal ablation for subpleural lung cancers. Author: Cao F1, Xie L1, Qi H1, Chen S1, Shen L1, Song Z2, Fan W1. Journal: Thorac Cancer. 2019 Apr 25. doi: 10.1111/1759-7714.13068. [Epub ahead of print]    PubMed      DOI
6.	Ultralow dose computed tomography protocol for hook-wire localization of solitary pulmonary nodules prior to video-assisted thoracoscopic surgery. Author: Liu B1, Fang J2, Jia H1, Sun Z3, Liao J4, Meng H1, Pan F1, Li C1. Journal: Thorac Cancer. 2019 May 1. doi: 10.1111/1759-7714.13075. [Epub ahead of print]    PubMed      DOI
7.	Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Author: Jiang M1, Zhou LY2, Xu N3, An Q3. Journal: Thorac Cancer. 2019 May 4. doi: 10.1111/1759-7714.13019. [Epub ahead of print]    PubMed      DOI
8.	MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin. Author: Zhou Y1, Zhao M2, Du Y3, Liu Y4, Zhao G5, Ye L5, Li Q6, Li H6, Wang X6, Liu X6, Guo Y6, Liu J6, Huang Y1. Journal: Thorac Cancer. 2019 May 9. doi: 10.1111/1759-7714.13087. [Epub ahead of print]    PubMed      DOI
9.	MS-275 potentiates the effect of YM-155 in lung adenocarcinoma via survivin downregulation induced by miR-138 and miR-195. Author: Luo BL1, Zhou Y1,2, Lv H3, Sun SH2, Tang WX2. Journal: Thorac Cancer. 2019 May 14. doi: 10.1111/1759-7714.13076. [Epub ahead of print]    PubMed      DOI
10.	Predictors of survival in non-small cell lung cancer patients with pleural effusion undergoing thoracoscopy. Author: Xie LX1, Wang XG1, You WJ1, Ma XB1, Wang YG1, Liu TT1, Jiang SJ1. Journal: Thorac Cancer. 2019 May 15. doi: 10.1111/1759-7714.13086. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore Lancet Respiratory Medicine 79 4.91 npj Primary Care Respiratory Medicine 16 2.42 Journal of Breath Research 45 2.75 Annals of Thoracic Medicine 29 1.50 Primary Care Respiratory Journal 44 0.00

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 297037 CANCER RESEARCH 165304 Molecular Medicine Reports 163998 International Journal of Nanomedicine 163857 CANCER LETTERS 158872 JOURNAL OF ETHNOPHARMACOLOGY 141042 BIOMEDICINE & PHARMACOTHERAPY 139717 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 135436 Theranostics 135219 International Journal of Environmental Research and Public Health 133053